ENB Therapeutics Company
ENB Therapeutics develops therapies to break barriers that prevent the majority of patients from responding to immunotherapy agents.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
New York, New York, United States
Founded Date:
2015
Employees Number:
1-10
Funding Status:
Early Stage Venture
Estimated Revenue:
Less than $1M
Register and Claim Ownership